Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P100
Near historical high
vs 2Y Ago
37x
Strong expansion
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 220.95% |
| Q3 2025 | 26.75% |
| Q2 2025 | 23.87% |
| Q1 2025 | -64.82% |
| Q4 2024 | 23.98% |
| Q3 2024 | -16.84% |
| Q2 2024 | 27.01% |
| Q1 2024 | -29.84% |
| Q4 2023 | 5.96% |
| Q3 2023 | 8.30% |
| Q2 2023 | 7.41% |
| Q1 2023 | -32.69% |
| Q4 2022 | -9.20% |
| Q3 2022 | -11.07% |
| Q2 2022 | 15.85% |
| Q1 2022 | 12.12% |
| Q4 2021 | -15.90% |
| Q3 2021 | -10.55% |
| Q2 2021 | -18.47% |
| Q1 2021 | -12.87% |
| Q4 2020 | -19.71% |
| Q3 2020 | -41.74% |
| Q2 2020 | 10.57% |
| Q1 2020 | -15.38% |
| Q4 2019 | -42.71% |
| Q3 2019 | -103702.44% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |